Tolerability of concurrent EBRT + Lu-PSMA for node-positive prostate cancer (PROQURE-1)

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514168-15-00

Enrollment

Registered

2024-05-23

Start date

2021-12-17

Completion date

2025-09-09

Last updated

2024-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N+M0 prostate cancer

None listed

Sex/Gender

Male

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026